NCT05949424 2023-11-29
OPTI-DOSE
University Medical Center Groningen
Phase 4 Unknown
Clinical Trials
33 trialsNCT05816642 2023-04-18
Application Circulating Tumor DNA Dynamic Monitoring in Clinical Treatment of Metastatic Renal Cell Carcinoma
RenJi Hospital
Phase NA Unknown
NCT02689167 2021-11-29
SURF
Centre Hospitalier Universitaire de Besancon
Phase 2 Unknown
NCT03025893 2021-04-19
STELLAR
Amsterdam UMC, location VUmc
Phase 2/3 Unknown
NCT03909724 2020-11-13
SUNRISE-CRC
Amsterdam UMC, location VUmc
Phase 2/3 Unknown
NCT03571438 2020-01-18
COMBOREIN
University Hospital, Grenoble
Phase NA Unknown
NCT03862768 2019-03-05
Role of Surgery in Patients With Focally Progressive Gastrointestinal Stromal Tumors (GISTs) After Imatinib Treatment
Shanghai Zhongshan Hospital
Phase NA Unknown
NCT01731925 2017-01-31
SUNLAND
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2 Unknown
NCT02446795 2017-01-18
QUASAR
Consorzio Oncotech
Phase 1/2 Unknown
NCT02928575 2016-10-10
Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase 2 Unknown
NCT02013089 2016-08-30
GITIC
Sun Yat-sen University
Phase NA Unknown
NCT01176799 2016-06-22
Randomized Study of Doxorubicin and Cyclophosphamide With or Without Intermittent Sunitinib in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer Patients With Measurable Primary Breast Tumor
National University Hospital, Singapore
Phase 2 Unknown
NCT01803503 2016-06-22
Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors
National University Hospital, Singapore
Phase 2 Unknown
NCT02790580 2016-06-06
Dose-dense Doxorubicin/Cyclophosphamide With Intermittent Low-dose Sunitinib in Breast Cancer Patients
National University Hospital, Singapore
Phase 2 Unknown
NCT02398552 2016-03-01
A Phase II Trila of Sunitinib Schedule 4/2 vs. Shedule 2/1 as First Line Therapy in Metastatic Renal Cell Carcinoma.
Peking University Cancer Hospital & Institute
Phase 2 Unknown
NCT02208128 2014-08-04
MORE
Heidelberg University
Phase NA Unknown
NCT00489944 2014-01-10
Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00717587 2014-01-10
Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00626509 2013-08-12
Sunitinib Before or After Surgery in Treating Patients With Metastatic Kidney Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00931450 2013-08-12
Sunitinib Malate and Exemestane in Treating Postmenopausal Women With Breast Cancer
National Cancer Institute (NCI)
Phase 1/2 Unknown
NCT01118039 2013-08-07
Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT01850147 2013-05-09
Sequential Use of Low-dose Sunitinib With Chemotherapy in Advanced NSCLC After Failure of Conventional Regimen
ChineseAMS
Phase 2 Unknown
NCT01216371 2012-02-13
SMAT
Association of Urologic Oncology (AUO)
Phase 2 Unknown
NCT00550810 2011-12-07
SMART
AHS Cancer Control Alberta
Phase 2 Unknown
NCT00753727 2011-06-23
SUNXRT
Australasian Sarcoma Study Group
Phase 1/2 Unknown
NCT01069770 2011-06-23
Neoadjuvant Sunitinib Treatment for Metastatic Clear Cell Renal Cell Carcinoma (RCC)
Korean Urological Oncology Society
Phase 2 Unknown
NCT01219751 2011-06-17
Trial Of Sunitinib In Advanced Non-Clear Cell Type Renal Cell Carcinoma
Asan Medical Center
Phase 2 Unknown
NCT01210053 2010-09-28
Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Third Military Medical University
Phase 2 Unknown
NCT00535379 2010-08-30
SURGE01-07
Medical University Innsbruck
Phase 2 Unknown
NCT00795171 2010-08-18
Biomarker Study for Sunitinib and Docetaxel in Prostate Cancer
Medical University of Vienna
Phase 2 Unknown
NCT01019798 2009-11-25
Salvage Therapy With Sunitinib,Docetaxel and Platinum on Metastatic or Unresectable Non Small Cell Lung Cancer
Taipei Medical University Hospital
Phase 2 Unknown
NCT00890110 2009-04-29
rcc
Hadassah Medical Organization
Phase 1/2 Unknown
NCT00818350 2009-01-07
Activity Study of Sunitinib In Metastatic Pretreated Urothelial Cancer
Campania Younger Oncologists Association
Phase 1/2 Unknown